学会発表(国際)

  • Kawahara T, Matsuyama Y. Doubly Robust Risk Estimation in the Presence of Informative Censoring Incorporating Time-Dependent Covariates. Joint Statistical Meeting 2015, Seattle, 10 Aug 2015.
  • Kobayashi A, Hasegawa K, Saiura A, Takayama T, Miyagawa S, Yamamoto J, Bandai Y, Teruya M, Yoshimi F, Kawasaki S, Koyama H, Oba M, Takahashi M, Mizunuma N, Matsuyama Y, Watanabe T, Makuuchi M, Kokudo N. A randomized controlled trial evaluating efficacy of adjuvant oral uracil-tegafur (UFT) with leucovorin (LV) after resection of colorectal cancer liver metastases: The UFT/LV study. 50th American Society of Clinical Oncology (ASCO) annual meeting.(abstract 3584). May 30-June 3, 2014, McCormick Place, Chicago, Illinois.
  • Nakamura M, Muramatsu T, Yokoi H, Okada H, Ochiai M, Suwa S, Matsuyama Y, Nanto S. J-DESsERT 3-Year Outcomes: Largest randomized trial stratified by diabetes mellitus presence, comparing sirolimus and paclitaxel eluting stents. Transcatheter Cardiovascular Therapeutics (TCT). October 27-November 1, 2013, The Moscone Center San Francisco, CA, USA.
  • Naito Y, Ohashi Y, Yokota I, Watanabe T, Iwata H, Ohsumi S, Ohno S, Hozumi Y, Yamamoto S, Takahashi M, Aihara T, Mukai H. Low body mass index (BMI) is associated with poor survival in Japanese patients with early breast cancer; an exploratory analysis of prospective randomized phase III trials N-SAS BC02 and 03. 2014 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 13, 2014. Session # P6-08-21.
  • Takeuchi Y, Higa S, Endo A, Matsui K, Watanabe S. The Risk of Acute Asthmatic Attacks Associated with Different Dosage Forms of Non-Steroidal Anti-Inflammatory Drugs: a Self-Controlled Case Series Study (poster presentation). 30th International Conference on Pharmacoepidemiology & Therapeutic Risk Management. Taipei. Oct 2014.
  • Nomura S, Shinozaki T, Hamada C. A new framework using g-estimation for placebo-controlled randomized phase 3 trials with extensive crossovers for biomarker-driven molecularly targeted oncology agents. 35th Annual Conference of the International Society for Clinical Biostatistics, Vienna, Austria. Aug 2014. Abstract C.25.5.
  • Shinozaki T, Matsuyama Y. Robust and efficient estimation of structural nested mean models in randomized trials with partial compliance using generalized method of moments. The XXVIIth International Biometric Conference, Florence, Italy. July 10, 2014. Poster Group 2, Abstract 35.
  • Yoshimura A, Iwata H, Hayashi T, Kobayashi N, Saito K, Tsuneizumi M, Sawaki M, Hattori M, Nakada T, Yokota I, Toyama T. A randomized phase II study evaluating the use of prydoxine to prevent hand-foot syndrome associated with capecitabine therapy for advanced or metastatic breast cancer. 2014 ASCO annual meeting, Chicago, IL, Jun 1, 2014. J Clin Oncol 32:5s, 2014 (suppl; abstr 9610).
  • Ohtani S, Masuda N, Im Y-H, Im S-A, Park B-W, Kim S-B, Yanagita Y, Takao S, Ohno S, Aogi K, Iwata H, Yoshidome K, Nishimura R, Lee E-S, Yokota I, Ohashi Y, Lee S-J, Toi M. Adjuvant capecitabine in breast cancer patients with pathologic residual disease after neoadjuvant chemotherapy : First safety analysis of CREATE-X (JBCRG-04). 2013 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 12, 2013. Session # P3-12-03.
  • Yokoyama T, Kunikane H, Katakami N, Yokota I, Saito Y, Shimozuma K, Ohashi Y, Eguchi K. A prospective analysis of the association between skeletal-related events and quality of life in patients with advanced lung cancer (CSP-HOR13). European Cancer Congress 2013 (ESMO38), Amsterdam, Netherlands, Sep 30, 2013. Abstract # P130.
  • Shinozaki T, Matsuyama Y, Ohashi Y. "Sensitivity analysis in randomized trials with partial compliance using generalized methods of moments applied to structural nested models" 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 28, 2013. Abstract C34.2.
  • Shinozaki T, Matsuyama Y, Ohashi Y. "Sensitivity analysis in randomized trials with partial compliance using generalized methods of moments applied to structural nested models" 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 28, 2013. Abstract C34.2.
  • Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-27, 2013. Abstract P136.
  • Yokota I, Matsuyama Y, Ohashi Y. Extension on a landmarking model using a fractional polynomial function for dynamic prediction. 34th Annual Conference of the International Society for Clinical Biostatistics, Munich, Germany, August 25-27, 2013. Abstract P136.
  • Yoshida K, Tsuburaya A, Kobayashi M, Yoshino S, Takahashi M, Takiguchi N, Tanabe K, Takahashi N, Imamura H, Tatsumoto N, Hara A, Nishikawa K, Fukushima R, Kurita A, Kojima H, Miyashita Y, Oba K, Buyse ME, Morita S, Sakamoto J. SAMIT: A phase III randomized clinical trial of adjuvant paclitaxel followed by oral fluorinated pyrimidines for locally advanced gastric cancer. Oral Abstract Session, Gastrointestinal (Noncolorectal) Cancer 2013 ASCO Annual Meeting.
  • Oba K, Burzykowski T. Validation of a surrogate endpoint by using the meta-analytic approach when the true endpoint is a rare binary-event. 34th Annual Conference of the International Society for Clinical Biostatistics 25 – 29 August 2013 in Munich, Germany.
  • Iwata H, Ohsumi S, Aogi K, Hozumi Y, Imoto S, Mukai H, Yokota I, Yamaguchi T, Ohashi Y, Watanabe T, Takatsuka Y, Aihara T. Long-term follow-up data of the side effect profile of anastrozole compared with tamoxifen in Japanese women : findings from N-SAS BC03 trial. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 6, 2012. Session # P2-13-07.
  • Imoto S, Osumi S, Aogi K, Hozumi Y, Mukai H, Iwata H, Yokota I, Yamaguchi T, Ohashi Y, Watanabe T, Takatsuka Y, Aihara T. Superior efficacy of anastrozole to tamoxifen as adjuvant therapy for postmenopausal patients with hormone-responsive breast cancer. Efficacy results of long-term follow-up data from N-SAS BC 03 trial. 2012 CTRC-AACR San Antonio Breast Cancer Symposium, San Antonio, TX, Dec 6, 2012. Abstract 850927.
  • Hideki Kitahara, Katsuhisa Waseda, Kenji Sakamoto, Ryotaro Yamada, Ching-Chang Huang, Daisaku Nakatani, Kenji Sakata, Osami Kawarada, Paul Yock, Yutaka Matsuyama, Hiroyoshi Yokoi, Masato Nakamura, Toshiya Muramatsu, Shinsuke Nanto, Peter Fitzgerald, Yasuhiro Honda. Impact of stent edge plaque burden on lumen preservation after DES implantation: A 3D-IVUS analysis from the J-DESsERT trial. Transcatheter Cardiovascular Therapeutics (TCT) 2012 (October 22-26) in Miami Beach Convention Center, Miami, USA.
  • Ching-Chang Huang, Hideki Kitahara, Katsuhisa Waseda, Kenji Sakamoto, Ryotaro Yamada, Osami Kawarada, Kenji Sakata, Daisaku Nakatani, Paul Yock, Yutaka Matsuyama, Hiroyoshi Yokoi, Toshiya Muramatsu, Masato Nakamura, Shinsuke Nanto, Peter Fitzgerald, Yasuhiro Honda. Impact of IVUS-detected calcification on subsequent neointimal hyperplasia after drug-eluting stent implantation: An IVUS substudy of the J-DESsERT trial. Transcatheter Cardiovascular Therapeutics (TCT) 2012 (October 22-26) in Miami Beach Convention Center, Miami, USA.

TOP